Question 1

What are the potential side effects of continuing treatment with natalizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Natalizumab Safety Extension Study clinical trial (NCT00276172). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this study fit into my overall treatment plan for multiple sclerosis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Natalizumab Safety Extension Study clinical trial (NCT00276172). Contact the study team or your healthcare provider for specific answers.

Question 3

What monitoring will be done during the study to ensure my safety?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Natalizumab Safety Extension Study clinical trial (NCT00276172). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Natalizumab Safety Extension Study clinical trial (NCT00276172). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience any adverse reactions during the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Natalizumab Safety Extension Study clinical trial (NCT00276172). Contact the study team or your healthcare provider for specific answers.

What this study is about